Evidence map›Paper›PMID 40586302›Full record

ArticleNucleic acids research2025

Potent optogenetic regulation of gene expression in mammalian cells for bioproduction and basic research.

Jeannette Gebel, Elisa Ciglieri, Rainer Stahl, Fraser Duthie, Fabian Frechen, Andreas Möglich, Herbert Müller-Hartmann, Hanns-Martin Schmidt, Dagmar Wachten

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jeannette GebelInstitute of Innate Immunity, Biophysical Imaging, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
Elisa CiglieriNingaloo Biosystems GmbH, 51011 Cologne, Germany.
Rainer StahlInstitute of Innate Immunity, Innate Immunity & Metaflammation, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
Fraser DuthieInstitute of Innate Immunity, Innate Immunity & Metaflammation, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
Fabian FrechenInstitute of Innate Immunity, Biophysical Imaging, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
Andreas MöglichDepartment of Biochemistry, University of Bayreuth, 95447Bayreuth, Germany.ORCID 0000-0002-7382-2772
Herbert Müller-HartmannNingaloo Biosystems GmbH, 51011 Cologne, Germany.
Hanns-Martin SchmidtNingaloo Biosystems GmbH, 51011 Cologne, Germany.
Dagmar WachtenInstitute of Innate Immunity, Biophysical Imaging, Medical Faculty, University of Bonn, 53127 Bonn, Germany.ORCID 0000-0003-4800-6332

Funding

BMBF KK55I0001CR2Deutsche Forschungsgemeinschaft 390873048
6 · The paper itself

Abstract

Precise temporal and spatial control of gene expression greatly benefits the study of specific cellular circuits and activities. Compared to chemical inducers, light-dependent control of gene expression by optogenetics achieves a higher spatial and temporal resolution. Beyond basic research, this could also prove decisive for manufacturing difficult-to-express proteins in pharmaceutical bioproduction. However, current optogenetic gene-expression systems limit this application in mammalian cells, as expression levels and the degree of induction upon light stimulation are insufficient. To overcome this limitation, we designed a photoswitch by fusing the blue light-activated light-oxygen-voltage receptor EL222 from Erythrobacter litoralis to the three transcriptional activator domains VP64, p65, and Rta in tandem. The resultant photoswitch, dubbed DEL-VPR, allows up to a 570-fold induction of target gene expression by blue light, thereby achieving expression levels of strong constitutive promoters. Here, we used DEL-VPR to enable light-induced expression of complex monoclonal and bispecific antibodies with reduced byproduct expression and increased yield of functional protein complexes. Our approach offers temporally controlled yet strong gene expression and applies to academic and industrial settings.

Indexed as

Gene Expression RegulationOptogeneticsAnimalsAntibodies, MonoclonalBacterial ProteinsHEK293 CellsHumansLightPromoter Regions, GeneticAntibodies, MonoclonalBacterial Proteins

Identifiers

PMID40586302
PMCPMC12207406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.